Resverlogix Corp. (TSX:RVX)
Canada · Delayed Price · Currency is CAD 0.1000
0.00 (0.00%)
May 1, 2026, 3:55 PM EST
Resverlogix Market Cap
Resverlogix has a market cap or net worth of CAD 31.67 million as of May 1, 2026. Its market cap has increased by 123.68% in one year.
Market Cap
31.67M
Enterprise Value
149.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since April 25, 2003, Resverlogix's market cap has increased from 22.94M to 31.67M, an increase of 38.04%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 31.67M | 10.12% |
| Dec 31, 2025 | 28.76M | 85.71% |
| Dec 31, 2024 | 15.48M | -18.72% |
| Dec 29, 2023 | 19.05M | -48.74% |
| Dec 30, 2022 | 37.17M | -70.01% |
| Dec 31, 2021 | 123.91M | -43.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 53.39M |
| Medicenna Therapeutics | 50.05M |
| Quantum BioPharma | 45.47M |
| BriaCell Therapeutics | 39.88M |
| MedMira | 38.60M |
| Defence Therapeutics | 38.55M |
| Telescope Innovations | 35.55M |
| Microbix Biosystems | 34.51M |